Program Website

http://www.fda.gov

Uniform Guidance

Uniform Guidance Interim Final Rule - HHS

Findings Library

2023 Compliance Supplement

Part 3 - Compliance Requirements

Part 3 - Compliance Requirements (redline version)

2022 Compliance Supplement

Part 3 - Compliance Requirements

Part 3 - Compliance Requirements (redline version)

Federal Regulations

45 cfr 75 - uniform administrative requirements, cost principles, and audit requirements for hhs awards

Other

hhs.gov - grants policies & regulations

CFDA Historical Index

2021

Action/Change Type: publish
Change Description: Food and Drug Administration Research


2020

Action/Change Type: publish
Change Description: Food and Drug Administration Research


2019

Action/Change Type: publish
Change Description: Food and Drug Administration Research

Program Objective

To assist institutions and organizations, to establish, expand, and improve research, demonstration, education and information dissemination activities; acquired immunodeficiency syndrome (AIDS), biologics, blood and blood products, therapeutics, vaccines and allergenic projects; drug hazards, human and veterinary drugs, clinical trials on drugs and devices for orphan products development; nutrition, sanitation and microbiological hazards; medical devices and diagnostic products, radiation emitting devices and materials; food safety and food additives. These programs are supported directly or indirectly by the following Centers and Offices: Center for Biologics Evaluation and Research (CBER); Center for Drug Evaluation and Research (CDER); Center for Devices and Radiological Health (CDRH); Center for Veterinary Medicine (CVM), Center for Food Safety and Applied Nutrition (CFSAN), National Center for Toxicological Research (NCTR), the Office of Orphan Products Development (OPD), the Center for Tobacco Products (CTP), and Office of Regulatory Affairs (ORA), and the Office of the Commissioner (OC). Small Business Innovation Research (SBIR) Programs: to stimulate technological innovation; to encourage the role of small business to meet Federal research and development needs; to increase private sector commercialization of innovations derived from Federal research and development; and to foster and encourage participation by minority and disadvantaged persons in technological innovation. Funding support for scientific conferences that are relevant to the FDA scientific mission and public health are also available.

Reported Expenditures

Expenditure Metrics

Contact Information

Kimberly M. Pendleton Chew 5630 Fishers Lane, Rockville, Maryland 20852 Email: kimberly.pendleton@fda.hhs.gov Phone: 240-402-7610

Legal Disclaimer

This information is accumulated from various sources, including but not limited to, beta.sam.gov, cfda.gov, whitehouse.gov and the web sites from various government agencies. The accuracy and completeness of this information has not been verified. Accordingly, we do provide any warranties over the accuracy or completeness of this information. By using this site, you agree to accept all responsibility for inaccurate or incomplete information contained herein.